Citadel Advisors’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,800
Closed -$320K 13319
2025
Q3
$320K Buy
+8,800
New +$299K ﹤0.01% 10208
2025
Q2
Sell
-12,700
Closed -$377K 13717
2025
Q1
$377K Sell
12,700
-1,300
-9% -$39K ﹤0.01% 9089
2024
Q4
$413K Sell
14,000
-13,300
-49% -$420K ﹤0.01% 8976
2024
Q3
$850K Sell
27,300
-5,600
-17% -$204K ﹤0.01% 7187
2024
Q2
$1.11M Sell
32,900
-16,600
-34% -$847K ﹤0.01% 6368
2024
Q1
$3.22M Buy
49,500
+31,500
+175% +$2.16M ﹤0.01% 4657
2023
Q4
$1.23M Sell
18,000
-10,300
-36% -$535K ﹤0.01% 6282
2023
Q3
$1.47M Buy
28,300
+13,300
+89% +$787K ﹤0.01% 5811
2023
Q2
$899K Sell
15,000
-2,200
-13% -$126K ﹤0.01% 6678
2023
Q1
$850K Buy
17,200
+6,000
+54% +$337K ﹤0.01% 7146
2022
Q4
$639K Buy
11,200
+6,200
+124% +$349K ﹤0.01% 7733
2022
Q3
$235K Sell
5,000
-2,300
-32% -$110K ﹤0.01% 10082
2022
Q2
$272K Buy
+7,300
New +$237K ﹤0.01% 10021

Other funds holding IMCR